In DUX4-expressing cancers, we observed lower mRNA levels of CXCL9 and CXCL10, chemokines which recruit T cells to the tumor site (Figure 2D,E; Nagarsheth et al., 2017). This evidence concerns the gene DUX4 and neoplasm.